DUBLIN--(Enterprise Ireland, a Dublin-based government agency helping startups find the path to success, today announced that it will host a two-part conference focused on the advantages of starting up a medtech business in Ireland with Wilson Sonsini Goodrich & Rosati, the leading provider of legal services to technology, life sciences, and growth enterprises worldwide. Ireland’s Prime Minister, Mr. Enda Kenny TD, will offer introductory remarks at the event, which will be held on March 21, 2013 at the Wilson Sonsini Goodrich & Rosati offices in Palo Alto, CA.)--
“We are excited to have the chance to inform early-stage medical device companies about Ireland’s medtech industry and the pro-business environment for medtech entrepreneurs”
The conference will include two panels, each packed with a lineup of experts and exclusive insights into the advantages of starting up and partnering in Ireland. Specifically, the sessions will address:
- Launching Your EU Strategy Through Partnering —The first session, moderated by David Cassack, vice president of content and managing director of medical devices at Elsevier Business Intelligence, will address why Ireland is the ideal place from which to launch a company’s European strategy by partnering with Irish companies, pointing to key factors such as manufacturing, distribution capabilities, and a low tax rate. Panelists include:
- Starting Up: Tapping Into Ireland’s Resources —The second session, led by Moderator Casey McGlynn, partner at Wilson Sonsini Goodrich & Rosati, will feature a panel of entrepreneurs, CEOs, and investors who will speak to the reasons why Ireland has proven to be an attractive location for U.S. entrepreneurs looking to launch medical device companies. Specifically, panelists will point to Ireland’s favorable regulatory environment, developed med tech infrastructure, and access to capital. Panelists include:
“We are excited to have the chance to inform early-stage medical device companies about Ireland’s medtech industry and the pro-business environment for medtech entrepreneurs,” says Enterprise Ireland CEO Frank Ryan. “Our hope is that these companies, having gained a clear understanding of the opportunities that exist overseas, will choose to launch their businesses in Ireland or partner with innovative Irish medtech companies to expedite their devices’ time to market, and ultimately make more life-improving medical solutions available to people around the world.”
To find out more about the conference and to register for the event, please visit the event website.
About Enterprise Ireland
Enterprise Ireland is the Government agency responsible for the development and internationalization of Irish enterprises. Its main aim is to boost exports and export-led jobs. Enterprise Ireland has 28 offices worldwide to help Irish firms develop overseas markets.
Each year, Enterprise Ireland organizes a series of targeted international trade missions, market visits, participation in international trade fairs and a large number of international buyer visits to Ireland focused on assisting Irish firms target and secure international contracts and overseas partners. Enterprise Ireland works directly with Irish firms to help them start up, develop their businesses, build competitiveness and innovate.
About Wilson Sonsini Goodrich & Rosati
For more than 50 years, Wilson Sonsini Goodrich & Rosati has offered a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leader in the fields of corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust, among many other areas of law. With deep roots in Silicon Valley, Wilson Sonsini Goodrich & Rosati has offices in Austin; Beijing; Brussels; Georgetown, DE; Hong Kong; New York; Palo Alto; San Diego; San Francisco; Seattle; Shanghai; and Washington, D.C. For more information, please visit www.wsgr.com.